AI For
Telemedicine

Ment Tech Labs builds AI-driven drug discovery solutions that help pharma and biotech teams make faster, clearer research decisions. From target discovery and compound screening to ADMET prediction and lead optimization, we turn complex scientific data into practical AI insights that reduce manual effort and move stronger candidates closer to development.
Pharma AI Programs Live
0 +
Hit Discovery Speed Up
0 +
Trial Recruitment Time Cut
0 %
GxP Validation Findings
0

Trusted & Certified

Quick Insights

What are AI Drug Discovery Solutions?

AI drug discovery solutions use intelligence to help with the beginning and complicated parts of medical research. These systems do not just rely on people looking over data. They can also look at information, chemical structures, research papers, lab results, and diseases. patterns. This helps scientists find targets, check compounds faster, and guess how a drug candidate will work before it gets to the expensive development stages.

For people who work in companies, biotech startups, and AI drug discovery companies, the real benefit is not just that it is faster. AI drug discovery solutions help research teams make decisions, stop doing the same work over and over, and focus on the candidates that have a better chance of working. This makes the process of finding drugs more practical based on facts and easier to scale up as the research goes from an idea to being proven to work. AI drug discovery solutions really help the medicine research process, and AI drug discovery is a part of this.

ISO 27001 · Certified

SOC 2 Type II · Compliant

Deloitte Fast 50 · Awarded

ERC-3643 · Compatible

KYC / AML · Integrated

MiCA-Ready · EU Compliant

VARA · UAE Licensed

OpenAI Partner · Certified

ISO 27001 · Certified

SOC 2 Type II · Compliant

Deloitte Fast 50 · Awarded

ERC-3643 · Compatible

KYC / AML · Integrated

MiCA-Ready · EU Compliant

VARA · UAE Licensed

OpenAI Partner · Certified

The Cost of Inaction

Every quarter without AI compresses competitor advantage in target selection, molecule design, and trial recruitment. Compounded across a pipeline, the gap is decisive.

The Evolution

From Legacy R&D to AI-Driven Drug Discovery

See how blockchain-powered solutions eliminate the inefficiencies of traditional finance.

Aspect
Legacy Method
Tokenized Solution
Hit Discovery
Virtual screening, 0.5% hit rate
Generative chemistry, 8x hit rate
ADMET Triage
Wet lab assay for every candidate
Calibrated ADMET filter inline, 38% cost cut
Trial Recruitment
Manual site selection is slow
AI site and patient matching, 42% faster
Patient Stratification
Single biomarker, broad trials
Multi-omics stratification, 2x POS
Pharmacovigilance
Manual case review
Adverse event NLP, 55% faster
RWE
Retrospective claims pulls
Continuous RWE platform for label expansion